跳至主要内容
临床试验/ACTRN12616001508460
ACTRN12616001508460已完成4 期

What is the extent to which platelet activation in response to infectious agents is reduced following administration of aspirin and ticagrelor in healthy volunteers?

Kathryn Hally0 个研究点目标入组 10 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
45 Years 至 65 Years(—)
性别
All

入选标准

  • Healthy, aged between 45 and 65

排除标准

  • i) known cardiovascular or inflammatory disease,
  • ii) platelet function disorder,
  • iii) a platelet count of less than 100x109/L,
  • iv) taken any anti-platelet, non-steroidal anti-inflammatory drugs or any cardiovascular or immune-modulating medication within 7 days prior to recruitment,
  • v) acute illness within 6 weeks prior to recruitment,
  • vi) pregnancy,
  • vii) diabetes mellitus,
  • viii) inability to provide written informed consent.

研究者

发起方
Kathryn Hally

相似试验